Human endothelial dysfunction: EDCFs

  • Agostino Virdis
  • Lorenzo Ghiadoni
  • Stefano Taddei
Cardiovascular Physiology


Human studies, conducted in the presence of clinical conditions characterized by endothelial dysfunction, evidenced that endothelial cells, in response to different agonists and physical stimuli, become a source of endothelium-derived contracting factors (EDCFs), mainly cyclooxygenase (COX)-derived prostanoids. Their production has been documented in several human diseases, mostly in essential hypertension and aging. The EDCF production was at first identified as responsible for impaired endothelium-dependent vasodilation in the forearm microcirculation of patients with essential hypertension. Subsequent studies demonstrated that COX-dependent EDCF products are also a characteristic of the aging process, and essential hypertension seems to only anticipate the phenomenon. Of note, in aging and hypertension, both indomethacin, a COX inhibitor, and vitamin C, an antioxidant, totally reverse the blunted vasodilation to acetylcholine by restoring NO availability, thus suggesting that EDCFs could be one of the major sources of oxygen free radicals. The presence of EDCFs was documented also in other clinical setting, such as coronary artery disease and estrogen deprivation. In conclusion, many human pathological conditions characterized by a decline in endothelial function are associated with a progressive decrease in NO bioavailability and increase in the production of EDCFs. The mechanisms that regulate the balance between NO and EDCFs and the processes transforming the endothelium from a protective organ to a source of vasoconstrictor, proaggregatory and promitogenic mediators, remain to be determined.


Acetylcholine Endothelium Oxidative stress 


Conflict of interest



  1. 1.
    Alvarez Y, Briones AM, Balfagon G, Alonso MJ, Salaices M (2005) Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. J Hypertens 23:767–777CrossRefPubMedGoogle Scholar
  2. 2.
    Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC et al (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26:1235–1241CrossRefPubMedGoogle Scholar
  3. 3.
    Belhassen L, Pelle G, Dubois-Rande JL, Adnot S (2003) Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin. J Am Coll Cardiol 41:1198–1204CrossRefPubMedGoogle Scholar
  4. 4.
    Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr, Lehman BT, Fan S, Osypiuk E, Vita JA (2004) Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 109:613–619CrossRefPubMedGoogle Scholar
  5. 5.
    Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, Kiowski W, Luscher TF, Mancia G, Natali A, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Spieker LE, Taddei S, Webb DJ (2005) Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 23:233–246CrossRefPubMedGoogle Scholar
  6. 6.
    Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM (1987) Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75:1102–1109PubMedGoogle Scholar
  7. 7.
    Calver A, Collier J, Moncada S, Vallance P (1992) Effect of local intra-arterial NG-monomethyl-l-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 10:1025–1031CrossRefPubMedGoogle Scholar
  8. 8.
    Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE (1994) Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24:471–476PubMedGoogle Scholar
  9. 9.
    Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, Lerman A, Mancia G, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Schiffrin EL, Taddei S, Webb DJ (2005) Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 23:7–17CrossRefPubMedGoogle Scholar
  10. 10.
    Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A (1993) Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 88:77–81PubMedGoogle Scholar
  11. 11.
    Egashira K, Inou T, Hirooka Y, Yamada A, Maruoka Y, Kai H, Sugimachi M, Suzuki S, Takeshita A (1993) Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest 91:29–37CrossRefPubMedGoogle Scholar
  12. 12.
    Fukushi J, Ono M, Morikawa W, Iwamoto Y, Kuwano M (2000) The activity of soluble VCAM-1 in angiogenesis stimulated by IL-4 and IL-13. J Immunol 165:2818–2823PubMedGoogle Scholar
  13. 13.
    Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376CrossRefPubMedGoogle Scholar
  14. 14.
    Garcia-Cohen EC, Marin J, Diez-Picazo LD, Baena AB, Salaices M, Rodriguez-Martinez MA (2000) Oxidative stress induced by tert-butyl hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats: role of cyclooxygenase-2 isoform. J Pharmacol Exp Ther 293:75–81PubMedGoogle Scholar
  15. 15.
    Ge T, Hughes H, Junquero DC, Wu KK, Vanhoutte PM, Boulanger CM (1995) Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res 76:1003–1010PubMedGoogle Scholar
  16. 16.
    Ghiadoni L, Taddei S, Virdis A, Sudano I, Di Legge V, Meola M, Di Venanzio L, Salvetti A (1998) Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension 32:25–32PubMedGoogle Scholar
  17. 17.
    Ghiadoni L, Versari D, Giannarelli C, Faita F, Taddei S (2008) Non-invasive diagnostic tools for investigating endothelial dysfunction. Curr Pharm Des 14:3715–3722CrossRefPubMedGoogle Scholar
  18. 18.
    Gisclard V, Miller VM, Vanhoutte PM (1988) Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 244:19–22PubMedGoogle Scholar
  19. 19.
    Gluais P, Paysant J, Badier-Commander C, Verbeuren T, Vanhoutte PM, Feletou M (2006) In SHR aorta, calcium ionophore A-23187 releases prostacyclin and thromboxane A2 as endothelium-derived contracting factors. Am J Physiol Heart Circ Physiol 291:H2255–2264CrossRefPubMedGoogle Scholar
  20. 20.
    Heitzer T, Yla-Herttuala S, Luoma J, Kurz S, Munzel T, Just H, Olschewski M, Drexler H (1996) Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 93:1346–1353PubMedGoogle Scholar
  21. 21.
    Hollenberg SM, Klein LW, Parrillo JE, Scherer M, Burns D, Tamburro P, Oberoi M, Johnson MR, Costanzo MR (2001) Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation 104:3091–3096CrossRefPubMedGoogle Scholar
  22. 22.
    Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Luscher TF (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314–1319PubMedGoogle Scholar
  23. 23.
    Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Ronnemaa T, Raitakari OT (2004) Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation 110:2918–2923CrossRefPubMedGoogle Scholar
  24. 24.
    Katz SD, Schwarz M, Yuen J, LeJemtel TH (1993) Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 88:55–61PubMedGoogle Scholar
  25. 25.
    Lerman A, Zeiher AM (2005) Endothelial function: cardiac events. Circulation 111:363–368CrossRefPubMedGoogle Scholar
  26. 26.
    Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P (1986) Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315:1046–1051PubMedGoogle Scholar
  27. 27.
    Luscher TF (1992) Endogenous and exogenous nitrates and their role in myocardial ischaemia. Br J Clin Pharmacol 34(Suppl 1):29S–35SPubMedGoogle Scholar
  28. 28.
    Panza JA, Quyyumi AA, Brush JE, Epstein SE (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323:22–27PubMedCrossRefGoogle Scholar
  29. 29.
    Park JB, Charbonneau F, Schiffrin EL (2001) Correlation of endothelial function in large and small arteries in human essential hypertension. J Hypertens 19:415–420CrossRefPubMedGoogle Scholar
  30. 30.
    Pinto S, Virdis A, Ghiadoni L, Bernini G, Lombardo M, Petraglia F, Genazzani AR, Taddei S, Salvetti A (1997) Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension 29:268–273PubMedGoogle Scholar
  31. 31.
    Plantinga Y, Ghiadoni L, Magagna A, Giannarelli C, Franzoni F, Taddei S, Salvetti A (2007) Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens 20:392–397CrossRefPubMedGoogle Scholar
  32. 32.
    Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO (1997) Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol 29:308–317CrossRefPubMedGoogle Scholar
  33. 33.
    Quyyumi AA, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO (1997) Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P. Circulation 95:104–110PubMedGoogle Scholar
  34. 34.
    Taddei S, Ghiadoni L, Virdis A, Versari D, Salvetti A (2003) Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategies. Curr Pharm Des 9:2385–2402CrossRefPubMedGoogle Scholar
  35. 35.
    Taddei S, Salvetti A (2002) Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens 20:1671–1674CrossRefPubMedGoogle Scholar
  36. 36.
    Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A (1997) Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 29:274–279PubMedGoogle Scholar
  37. 37.
    Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A (1998) Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97:2222–2229PubMedGoogle Scholar
  38. 38.
    Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, Pinto S, Salvetti A (1996) Menopause is associated with endothelial dysfunction in women. Hypertension 28:576–582PubMedGoogle Scholar
  39. 39.
    Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A (2001) Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38:274–279PubMedGoogle Scholar
  40. 40.
    Taddei S, Virdis A, Mattei P, Ghiadoni L, Fasolo CB, Sudano I, Salvetti A (1997) Hypertension causes premature aging of endothelial function in humans. Hypertension 29:736–743PubMedGoogle Scholar
  41. 41.
    Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, Sudano I, Salvetti A (1995) Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 91:1981–1987PubMedGoogle Scholar
  42. 42.
    Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A (1996) Defective l-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 94:1298–1303PubMedGoogle Scholar
  43. 43.
    Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A (1995) Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation 92:2911–2918PubMedGoogle Scholar
  44. 44.
    Taddei S, Virdis A, Mattei P, Salvetti A (1993) Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21:929–933PubMedGoogle Scholar
  45. 45.
    Touyz RM (2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44:248–252CrossRefPubMedGoogle Scholar
  46. 46.
    Vallance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997–1000CrossRefPubMedGoogle Scholar
  47. 47.
    Vanhoutte PM (1989) Endothelium and control of vascular function. State of the art lecture. Hypertension 13:658–667PubMedGoogle Scholar
  48. 48.
    Vanhoutte PM, Feletou M, Taddei S (2005) Endothelium-dependent contractions in hypertension. Br J Pharmacol 144:449–458CrossRefPubMedGoogle Scholar
  49. 49.
    Vanhoutte PM, Tang EH (2008) Endothelium-dependent contractions: when a good guy turns bad! J Physiol 586:5295–5304CrossRefPubMedGoogle Scholar
  50. 50.
    Virdis A, Colucci R, Fornai M, Duranti E, Giannarelli C, Bernardini N, Segnani C, Ippolito C, Antonioli L, Blandizzi C, Taddei S, Salvetti A, Del Tacca M (2007) Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension 49:679–686CrossRefPubMedGoogle Scholar
  51. 51.
    Virdis A, Colucci R, Versari D, Ghisu N, Fornai M, Antonioli L, Duranti E, Daghini E, Giannarelli C, Blandizzi C, Taddei S, Del Tacca M (2009) Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids. Hypertension 53:1008–1016CrossRefPubMedGoogle Scholar
  52. 52.
    Virdis A, Ghiadoni L, Pinto S, Lombardo M, Petraglia F, Gennazzani A, Buralli S, Taddei S, Salvetti A (2000) Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women. Circulation 101:2258–2263PubMedGoogle Scholar
  53. 53.
    Virdis A, Ghiadoni L, Versari D, Giannarelli C, Salvetti A, Taddei S (2008) Endothelial function assessment in complicated hypertension. Curr Pharm Des 14:1761–1770CrossRefPubMedGoogle Scholar
  54. 54.
    Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P (1990) Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81:491–497PubMedGoogle Scholar
  55. 55.
    Williams JK, Adams MR, Klopfenstein HS (1990) Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81:1680–1687PubMedGoogle Scholar
  56. 56.
    Yang D, Feletou M, Boulanger CM, Wu HF, Levens N, Zhang JN, Vanhoutte PM (2002) Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br J Pharmacol 136:104–110CrossRefPubMedGoogle Scholar
  57. 57.
    Zeiher AM (1994) Endothelial modulation of coronary vasomotor tone in humans. Effects of atherosclerosis and risk factors for coronary artery disease. Arzneimittelforschung 44:439–442PubMedGoogle Scholar
  58. 58.
    Zeiher AM, Drexler H, Saurbier B, Just H (1993) Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 92:652–662CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Agostino Virdis
    • 1
  • Lorenzo Ghiadoni
    • 1
  • Stefano Taddei
    • 1
  1. 1.Department of Internal MedicineUniversity of PisaPisaItaly

Personalised recommendations